Khushalani, N. I., El-Haddad, G., Budzevich, M., Schell, M. J., Li, J., Moros, E. G., Tichacek, C., Gibbons, W. R., Rogers, R. E., Nickels, M. L., Johnson, I., Eroglu, Z., Karapetyan, L., Brohl, A. S., Markowitz, J., Tarhini, A., Hayes, K., Hazlehurst, L., McLaughlin, M., Morse, D. L. (2026). Final results of a first-in-human study of the MC1R-targeting radiopharmaceutical 225 actinium MTI-201 ( 225 Ac-MTI-201) in metastatic uveal melanoma (mUM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3099